AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Orthometrix, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
4.7K
AVG Volume
729
Trailing/Forward PE
0.01/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
01M2M3M06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
08 Q31.46M
08 Q22.05M
08 Q12.19M
07 Q42.41M
07 Q32.07M
07 Q21.85M
07 Q12.19M
06 Q42.36M
06 Q32.32M
06 Q22.11M
Net Income (USD) · TTM
-3M-2M-1M006 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
08 Q3-959.26K
08 Q2-795.6K
08 Q1-953.03K
07 Q4-1.08M
07 Q3-1.87M
07 Q2-2.12M
07 Q1-2.09M
06 Q4-1.98M
06 Q3-1.91M
06 Q2-2.08M
Operating Income (USD) · TTM
01M2M3M06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
08 Q3551.7K
08 Q2321.2K
08 Q1378.96K
07 Q4416.04K
07 Q31.14M
07 Q21.42M
07 Q11.53M
06 Q41.64M
06 Q31.79M
06 Q22.07M
EBITDA (USD) · TTM
-2M-1M01M06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
08 Q3-488.13K
08 Q240.6K
08 Q1-15.96K
07 Q4-51.8K
07 Q3-693.82K
07 Q2-1.23M
07 Q1-1.31M
06 Q4-1.41M
06 Q3-1.63M
06 Q2-1.99M
Cash Flows (USD) · TTM
-2M-1.5M-1M-500K006 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
08 Q3-572.6K
08 Q2-389.92K
08 Q1-237.81K
07 Q4-209.22K
07 Q3-565.57K
07 Q2-628.76K
07 Q1-1.25M
06 Q4-1.2M
06 Q3-1.44M
06 Q2-1.83M
EPS (USD) · TTM
-0.06-0.04-0.02006 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
08 Q3-0.03
08 Q2-0.03
08 Q1-0.03
07 Q4-0.03
07 Q3-0.04
07 Q2-0.05
07 Q1-0.05
06 Q4-0.05
06 Q3-0.05
06 Q2-0.05
Expenses (USD) · TTM
01M2M3M4MR&DSG&ACapex06 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
08 Q31.14M
08 Q21.24M
08 Q11.38M
07 Q41.5M
07 Q32.1M
07 Q22.36M
07 Q12.76M
06 Q43.15M
06 Q33.32M
06 Q23.44M
Shares Outstanding · TTM
-150K-100K-50K006 Q206 Q306 Q407 Q107 Q207 Q307 Q408 Q108 Q208 Q3
OMRX Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
08 Q3-106.44K
08 Q2-115.2K
08 Q1-74.68K
07 Q4-90.74K
07 Q3-90.74K
07 Q2-77.8K
07 Q1-77.8K
06 Q40
06 Q30
06 Q20
PE Ratio
0.20.30.40.50.6med 0.36Oct 02Dec 02Feb 03Apr 03Jun 03Aug 03Sep 03
OMRX PE Ratio by quarter
PeriodPE Ratio
Sep 030.24
Sep 030.32
Sep 030.32
Sep 030.32
Aug 030.32
Aug 030.32
Aug 030.32
Aug 030.32
Aug 030.32
Jul 030.36
Jul 030.36
Jul 030.36
Jul 030.36
Jun 030.41
Jun 030.41
Jun 030.36
Jun 030.36
May 030.36
May 030.36
May 030.36
May 030.36
May 030.36
Apr 030.36
Apr 030.36
Apr 030.36
Apr 030.36
Mar 030.39
Mar 030.39
Mar 030.35
Mar 030.35
Feb 030.44
Feb 030.44
Feb 030.44
Feb 030.44
Jan 030.39
Jan 030.44
Jan 030.35
Jan 030.52
Jan 030.39
Dec 020.37
Dec 020.37
Dec 020.37
Dec 020.41
Nov 020.37
Nov 020.37
Nov 020.37
Nov 020.33
Nov 020.37
Oct 020.33
Oct 020.34
Oct 020.41
Oct 020.41
Free Cash Flow Yield
-11535.5%-11535.25%-11535%-11534.75%-11534.5%-11534.25%med -11535.37%Jan 25May 25Sep 25Jan 26May 26Sep 26
OMRX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-11535.37%
Sep 26-11535.37%
Aug 26-11535.37%
Aug 26-11535.37%
Aug 26-11535.37%
Aug 26-11535.37%
Jul 26-11535.37%
Jul 26-11535.37%
Jul 26-11535.37%
Jul 26-11535.37%
Jul 26-11535.37%
Jun 26-11535.37%
Jun 26-11535.37%
Jun 26-11535.37%
Jun 26-11535.37%
May 26-11535.37%
May 26-11535.37%
May 26-11535.37%
May 26-11535.37%
May 26-11535.37%
Apr 26-11535.37%
Apr 26-11535.37%
Apr 26-11535.37%
Apr 26-11535.37%
Mar 26-11535.37%
Mar 26-11535.37%
Mar 26-11535.37%
Mar 26-11535.37%
Feb 26-11535.37%
Feb 26-11535.37%
Feb 26-11535.37%
Feb 26-11535.37%
Jan 26-11535.37%
Jan 26-11535.37%
Jan 26-11535.37%
Jan 26-11535.37%
Jan 26-11535.37%
Dec 25-11535.37%
Dec 25-11535.37%
Dec 25-11535.37%
Dec 25-11535.37%
Nov 25-11535.37%
Nov 25-11535.37%
Nov 25-11535.37%
Nov 25-11535.37%
Oct 25-11535.37%
Oct 25-11535.37%
Oct 25-11535.37%
Oct 25-11535.37%
Oct 25-11535.37%
Sep 25-11535.37%
Sep 25-11535.37%
Sep 25-11535.37%
Sep 25-11535.37%
Aug 25-11535.37%
Aug 25-11535.37%
Aug 25-11535.37%
Aug 25-11535.37%
Aug 25-11535.37%
Jul 25-11535.37%
Jul 25-11535.37%
Jul 25-11535.37%
Jul 25-11535.37%
Jun 25-11535.37%
Jun 25-11535.37%
Jun 25-11535.37%
Jun 25-11535.37%
May 25-11535.37%
May 25-11535.37%
May 25-11535.37%
May 25-11535.37%
May 25-11535.37%
Apr 25-11535.37%
Apr 25-11535.37%
Apr 25-11535.37%
Apr 25-11535.37%
Mar 25-11535.37%
Mar 25-11535.37%
Mar 25-11535.37%
Mar 25-11535.37%
Feb 25-11535.37%
Feb 25-11535.37%
Feb 25-11535.37%
Feb 25-11535.37%
Jan 25-11535.37%
Jan 25-11535.37%
Jan 25-11535.37%
Jan 25-11535.37%
Jan 25-11535.37%
Dec 24-11535.37%
Dec 24-11535.37%
Dec 24-11535.37%
Dec 24-11535.37%
Nov 24-11535.37%
Nov 24-11535.37%
Nov 24-11535.37%
Nov 24-11535.37%
Nov 24-11535.37%
Oct 24-11535.37%
Oct 24-11535.37%
Price to Sales
00.250.50.7511.25med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
OMRX Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
EV/EBITDA
60708090100med 71.59Oct 08Oct 08Oct 08Nov 08Nov 08Dec 08Dec 08
OMRX EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 0863.43
Dec 0894.9
Dec 0894.9
Dec 0877.41
Nov 0871.59
Nov 0871.59
Nov 0871.59
Nov 0871.59
Oct 0871.59
Oct 0871.59
Oct 0871.59
Oct 0871.59
Oct 0871.59
Price to Book
010203040med 2.34Sep 00Dec 02Mar 03Jun 03Sep 03Sep 05Dec 05
OMRX Price to Book by quarter
PeriodPrice to Book
Dec 0520.19
Dec 0528.73
Dec 0528.73
Dec 0532.61
Nov 0532.61
Nov 0534.16
Nov 0528.73
Nov 0531.83
Oct 0534.16
Oct 0535.72
Oct 0531.83
Oct 0535.72
Sep 0535.72
Sep 0514.78
Sep 0513.55
Sep 0514.17
Sep 0512.32
Aug 0517.25
Aug 0517.25
Aug 0513.55
Aug 0513.55
Jul 0512.32
Jul 0512.32
Jul 0520.33
Jul 0513.55
Jul 0512.94
Sep 034.24
Sep 035.66
Sep 035.66
Sep 035.66
Aug 035.66
Aug 035.66
Aug 035.66
Aug 035.66
Aug 035.66
Jul 036.36
Jul 036.36
Jul 036.36
Jul 036.36
Jun 032.63
Jun 032.63
Jun 032.34
Jun 032.34
May 032.34
May 032.34
May 032.34
May 032.34
May 032.34
Apr 032.34
Apr 032.34
Apr 032.34
Apr 032.34
Mar 031.29
Mar 031.29
Mar 031.15
Mar 031.15
Feb 031.43
Feb 031.43
Feb 031.43
Feb 031.43
Jan 031.29
Jan 031.43
Jan 031.15
Jan 031.72
Jan 031.29
Dec 020.75
Dec 020.75
Dec 020.75
Dec 020.83
Nov 020.75
Nov 020.75
Nov 020.75
Nov 020.67
Nov 020.75
Oct 020.67
Oct 020.68
Oct 020.83
Oct 020.83
Sep 000.7
Sep 000.67
Sep 000.78
Sep 000.74
Aug 000.89
Aug 000.89
Aug 000.89
Aug 000.89
Jul 000.89
Jul 000.89
Jul 001.19
Jul 001.19
Jun 000.89
Orthometrix, Inc.
OMRX
Stockpicker

Video analysis: OMRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.